EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single Cancer Center Experience on Patient Blood Management Eligibility in Oncological Surgery

Camilla L'Acqua iD, Roberto Lillini iD, Rosamaria Limuti, Flavio Arienti, Chiara Maura Ciniselli iD, Paolo Verderio iD, Ilaria Cavallo iD, Paolo Baili iD, Giulia Perrone

Journal of Clinical Medicine · 26.03.2026 · 15 (7) · 2543

DOI: 10.3390/jcm15072543 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 26.03.2026. Verfasst von Camilla L'Acqua und 8 weiteren Autor:innen. Beteiligte Einrichtung: Anesthesia and Intensive Care Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian, 1, 20133 Milano, Italy. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Accurate identification of patients at high risk of perioperative blood transfusion is essential for optimizing patient blood management (PBM) strategies in oncological surgery. However, the performance of standard PBM eligibility criteria in real-world oncological settings remains incompletely characterized. Material and Methods: We conducted a retrospective, single-center analysis of 4228 consecutive patients undergoing elective oncological surgery of any complexity or liver transplantation over a 9-month period to assess transfusion need and estimate access to preoperative patient blood management (PBM) strategies to improve anemia management. Transfusion events were assessed within 24 h after surgery (PS24) and during the perioperative period (PO; 48 h before to 72 h after surgery). Two PBM eligibility strategies were applied to the same patient cohort and compared: (A) an observational approach, based on predefined PBM indicators (transfusion rate and transfusion index by surgical complexity), and (B) a multivariable modeling approach based on pre- and intraoperative anesthesiology assessment to estimate individual transfusion risk. Predictive performance of both strategies was evaluated using accuracy, Cramér’s V, area under the receiver-operating characteristic curve (AUC-ROC), and Brier score.

Results

Overall, 7.7% of patients received transfusion within PS24 and 9.2% during PO. According to the observational approach, 23.8% of patients were classified as PBM-eligible, accounting for 89.2% of PS24 transfusions and 87.1% of PO transfusions. In the multivariable modeling approach, independent predictors of transfusion included surgical type (e.g., sarcoma surgery: OR 22.8 for PS24; OR 6.3 for PO; vs. senology surgery OR 1 for PS24; OR 1 for PO, respectively), anemia severity (moderate anemia: OR 64.3 and OR 107.9, respectively and mild anemia OR 3.38 and OR 3.65, respectively), high surgical complexity, operative time >3 h (>3 h: OR 8.83 and OR 8.65, respectively vs.

Schlagwörter

Stichwörter der Autor:innen

anemiaoncological surgerypatient blood managementperioperative caretransfusion risk

Autor:innen und Institutionen

  • Anesthesia and Intensive Care Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian, 1, 20133 Milano, Italy.
  • Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian, 1, 20133 Milano, Italy.
  • Immunohematology and Transfusion Medicine Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian, 1, 20133 Milano, Italy.
  • Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian, 1, 20133 Milano, Italy.
  • Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian, 1, 20133 Milano, Italy.

ORCID-Profile: Camilla L'Acqua, Roberto Lillini, Chiara Maura Ciniselli, Paolo Verderio, Ilaria Cavallo, Paolo Baili

Förderung

  • Italian Ministry of Health

Zitieren

APA

L'Acqua, C., Lillini, R., Limuti, R., Arienti, F., Ciniselli, C. M., Verderio, P., Cavallo, I., Baili, P., & Perrone, G. (2026). Single Cancer Center Experience on Patient Blood Management Eligibility in Oncological Surgery. Journal of Clinical Medicine, 15(7), 2543. https://doi.org/10.3390/jcm15072543

Vancouver

L'Acqua C, Lillini R, Limuti R, Arienti F, Ciniselli CM, Verderio P, et al. Single Cancer Center Experience on Patient Blood Management Eligibility in Oncological Surgery. Journal of Clinical Medicine. 2026;15(7):2543. doi:10.3390/jcm15072543

BibTeX
@article{LAcqua2026,
  author = {L'Acqua, Camilla and Lillini, Roberto and Limuti, Rosamaria and Arienti, Flavio and Ciniselli, Chiara Maura and Verderio, Paolo and Cavallo, Ilaria and Baili, Paolo and Perrone, Giulia},
  title = {Single Cancer Center Experience on Patient Blood Management Eligibility in Oncological Surgery},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {7},
  pages = {2543},
  doi = {10.3390/jcm15072543}
}
Kostenlos starten →